A carregar...

The efficacy of (+)-4-propyl-9-hydroxynaphthoxazine as adjunctive therapy in Parkinson's disease.

(+)-4-propyl-9-hydroxynaphthoxazine (PHNO) is a novel selective D2 agonist. The efficacy and safety of PHNO was studied in 10 Parkinsonian patients (Hoehn and Yahr Stage II or III) who continued to receive levodopa/carbidopa. At the lowest dose administered (0.25 mg tid), nine of the 10 patients imp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Weiner, W J, Factor, S A, Sanchez-Ramos, J R
Formato: Artigo
Idioma:Inglês
Publicado em: 1989
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1032023/
https://ncbi.nlm.nih.gov/pubmed/2746265
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!